The Screen for Cognitive Impairment in Psychiatry in Patients with Borderline Personality Disorder

Overview

Journal Personal Ment Health

Specialties Psychiatry
Psychology

Date 2022 Feb 11

PMID 35146968

Authors

Federica Folesani

Martino Belvederi Murri

Bruno Biancosino

Silvia Costa

Luigi Zerbinati

Rosangela Caruso

Maria Giulia Nanni

Tommaso Toffanin

Maria Ferrara

Scot E Purdon

Luigi Grassi

Affiliations

Soon will be listed here.

Abstract

Cognitive deficits are common in borderline personality disorder (BPD) and appear to be associated with psychopathology, functioning and outcome. The availability of a cognitive screening instrument could be of use in clinical settings in order to assess neurocognition in BPD patients. The Screen for Cognitive Impairment for Psychiatry (SCIP) proved to be reliable in different psychiatric populations, but it has not yet been validated in personality disorders. The purpose of this study is therefore to evaluate its psychometric properties in a sample of 58 BPD patients. The SCIP was validated against the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and the Trail Making Test A and B (TMT A and B). The receiver operator curve analysis displayed an acceptable convergent validity (total score AUC: 0.78, 95% CI: 0.70-0.86; Se: 75%, Sp: 72%). A cut-off total score of 80 identified 81% of patients as cognitively impaired. The exploratory factor analysis displayed a one-factor solution explaining 55.8% of the total variance. The SCIP displayed adequate psychometric properties in BPD and could be integrated in the routine clinical assessment to provide a preliminary evaluation of cognitive features for BPD.

Citing Articles

The screen for cognitive impairment in psychiatry in patients with borderline personality disorder.

Folesani F, Belvederi Murri M, Biancosino B, Costa S, Zerbinati L, Caruso R Personal Ment Health. 2022; 16(4):279-289.

PMID: 35146968 PMC: 9788074. DOI: 10.1002/pmh.1539.

References

Svaldi J, Philipsen A, Matthies S . Risky decision-making in borderline personality disorder. Psychiatry Res. 2012; 197(1-2):112-8. DOI: 10.1016/j.psychres.2012.01.014. View

Sanchez-Cubillo I, Perianez J, Adrover-Roig D, Rodriguez-Sanchez J, Rios-Lago M, Tirapu J . Construct validity of the Trail Making Test: role of task-switching, working memory, inhibition/interference control, and visuomotor abilities. J Int Neuropsychol Soc. 2009; 15(3):438-50. DOI: 10.1017/S1355617709090626. View

Barcelo F, Sanz M, Molina V, RUBIA F . The Wisconsin Card Sorting Test and the assessment of frontal function: a validation study with event-related potentials. Neuropsychologia. 1997; 35(4):399-408. DOI: 10.1016/s0028-3932(96)00096-6. View

Mensebach C, Beblo T, Driessen M, Wingenfeld K, Mertens M, Rullkoetter N . Neural correlates of episodic and semantic memory retrieval in borderline personality disorder: an fMRI study. Psychiatry Res. 2009; 171(2):94-105. DOI: 10.1016/j.pscychresns.2008.02.006. View

Rojo E, Pino O, Guilera G, Gomez-Benito J, Purdon S, Crespo-Facorro B . Neurocognitive diagnosis and cut-off scores of the Screen for Cognitive Impairment in Psychiatry (SCIP-S). Schizophr Res. 2009; 116(2-3):243-51. DOI: 10.1016/j.schres.2009.08.005. View

Skodol A, Buckley P, Charles E . Is there a characteristic pattern to the treatment history of clinic outpatients with borderline personality?. J Nerv Ment Dis. 1983; 171(7):405-10. DOI: 10.1097/00005053-198307000-00003. View

Guilera G, Pino O, Gomez-Benito J, Rojo J, Vieta E, Tabares-Seisdedos R . Clinical usefulness of the screen for cognitive impairment in psychiatry (SCIP-S) scale in patients with type I bipolar disorder. Health Qual Life Outcomes. 2009; 7:28. PMC: 2671485. DOI: 10.1186/1477-7525-7-28. View

Gold J, Queern C, Iannone V, Buchanan R . Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia I: sensitivity, reliability, and validity. Am J Psychiatry. 1999; 156(12):1944-50. DOI: 10.1176/ajp.156.12.1944. View

Bakkour N, Samp J, Akhras K, El Hammi E, Soussi I, Zahra F . Systematic review of appropriate cognitive assessment instruments used in clinical trials of schizophrenia, major depressive disorder and bipolar disorder. Psychiatry Res. 2014; 216(3):291-302. DOI: 10.1016/j.psychres.2014.02.014. View

10.

Belvederi Murri M, Folesani F, Costa S, Morelli A, Scillitani V, Guaiana G . Italian Validation of the Screen for Cognitive Impairment in Psychiatry. Community Ment Health J. 2020; 56(8):1411-1418. DOI: 10.1007/s10597-020-00583-x. View

11.

Mahurin R, Velligan D, Hazleton B, Davis J, Eckert S, Miller A . Trail making test errors and executive function in schizophrenia and depression. Clin Neuropsychol. 2006; 20(2):271-88. DOI: 10.1080/13854040590947498. View

12.

Gunderson J, Herpertz S, Skodol A, Torgersen S, Zanarini M . Borderline personality disorder. Nat Rev Dis Primers. 2018; 4:18029. DOI: 10.1038/nrdp.2018.29. View

13.

Giovagnoli A, Del Pesce M, Mascheroni S, Simoncelli M, Laiacona M, Capitani E . Trail making test: normative values from 287 normal adult controls. Ital J Neurol Sci. 1996; 17(4):305-9. DOI: 10.1007/BF01997792. View

14.

Jensen J, Stottrup M, Nayberg E, Knorr U, Ullum H, Purdon S . Optimising screening for cognitive dysfunction in bipolar disorder: Validation and evaluation of objective and subjective tools. J Affect Disord. 2015; 187:10-9. DOI: 10.1016/j.jad.2015.07.039. View

15.

Folstein M, Folstein S, McHugh P . "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-98. DOI: 10.1016/0022-3956(75)90026-6. View

16.

Ott C, Bjertrup A, Jensen J, Ullum H, Sjaelland R, Purdon S . Screening for cognitive dysfunction in unipolar depression: Validation and evaluation of objective and subjective tools. J Affect Disord. 2015; 190:607-615. DOI: 10.1016/j.jad.2015.10.059. View

17.

Belvederi Murri M, Folesani F, Costa S, Biancosino B, Colla C, Zerbinati L . Screening for cognitive impairment in non-affective psychoses: A comparison between the SCIP and the MoCA. Schizophr Res. 2020; 218:188-194. DOI: 10.1016/j.schres.2020.01.005. View

18.

Ott C, Knorr U, Jespersen A, Obenhausen K, Roen I, Purdon S . Norms for the Screen for Cognitive Impairment in Psychiatry and cognitive trajectories in bipolar disorder. J Affect Disord. 2020; 281:33-40. DOI: 10.1016/j.jad.2020.11.119. View

19.

Vita A, Deste G, Barlati S, Poli R, Cacciani P, De Peri L . Feasibility and effectiveness of cognitive remediation in the treatment of borderline personality disorder. Neuropsychol Rehabil. 2016; 28(3):416-428. DOI: 10.1080/09602011.2016.1148054. View

20.

Laiacona M, Inzaghi M, De Tanti A, Capitani E . Wisconsin card sorting test: a new global score, with Italian norms, and its relationship with the Weigl sorting test. Neurol Sci. 2001; 21(5):279-91. DOI: 10.1007/s100720070065. View